Endospan Ltd.

25 patents currently held · Updated Nov 14, 2026

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Mar 2028

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due May 14 to 26, 2027 · next May 14
1 fee due Sep 30, 2027
The maintenance fee for Stent system with radial-expansion locking (US 10,603,197) comes due Sep 30, 2027. Unpaid by Mar 31, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 8,709,068	Multi-component bifurcated stent-graft systems In force Term ends Mar 5, 2028 · From the USPTO record	In force	Term ends Mar 5, 2028	From the USPTO record
US 8,317,856	Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same In force Term ends Oct 7, 2028 · From the USPTO record	In force	Term ends Oct 7, 2028	From the USPTO record
US 8,945,203	Multi-Component Stent-Graft System for Implantation in a Blood Vessel with Multiple Branches In force Term ends Nov 30, 2030 · High confidence	In force	Term ends Nov 30, 2030	High confidence
US 10,888,413	Multi-Component Stent-Graft System for Implantation in a Blood Vessel with Multiple Branches In force Term ends Nov 30, 2030 · High confidence	In force	Term ends Nov 30, 2030	High confidence
US 9,918,825	Vascular prosthesis for treating aneurysms In force Term ends Mar 25, 2031 · From the USPTO record	In force	Term ends Mar 25, 2031	From the USPTO record
US 11,090,148	Vascular prosthesis for treating aneurysms In force Term ends Apr 27, 2031 · From the USPTO record	In force	Term ends Apr 27, 2031	From the USPTO record
US 8,870,938	Vascular prostheses for treating aneurysms In force Term ends Aug 22, 2031 · From the USPTO record	In force	Term ends Aug 22, 2031	From the USPTO record
US 10,201,413	Multi-Component Stent-Graft System for Implantation in a Blood Vessel with Multiple Branches In force Term ends May 28, 2032 · High confidence	In force	Term ends May 28, 2032	High confidence
US 8,574,287	Stents incorporating a plurality of strain-distribution locations In force Term ends Jun 14, 2032 · From the USPTO record	In force	Term ends Jun 14, 2032	From the USPTO record
US 9,839,510	Stent-grafts with post-deployment variable radial displacement In force Term ends Sep 18, 2032 · From the USPTO record	In force	Term ends Sep 18, 2032	From the USPTO record

10 of 25 patents shown.

Pro members see all 25.

Pro members: see all 25 patents

Also on record, not counted in the 25: 1 patent in force now held by others · 11 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 12 no status recorded

List them